• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肿瘤微环境的肝细胞癌独立不良预后亚型。

An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.

机构信息

Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Department of General Surgery, Hangzhou Mingzhou Hospital, Hangzhou, China.

出版信息

J Int Med Res. 2021 Feb;49(2):300060520980646. doi: 10.1177/0300060520980646.

DOI:10.1177/0300060520980646
PMID:33567957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7883156/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is a highly malignant tumor with a particularly poor prognosis. The tumor microenvironment (TME) is closely associated with tumorigenesis, progression, and treatment. However, the relationship between TME genes and HCC patient prognosis is poorly understood.

METHODS

In this study, we identified two prognostic subtypes based on the TME using data from The Cancer Genome Atlas and Gene Expression Omnibus. The Microenvironment Cell Populations-counter method was used to evaluate immune cell infiltration in HCC. Differentially expressed genes between molecular subtypes were calculated with the Limma package, and clusterProfiler was used for Gene Ontology and Kyoto Encyclopedia of Genes and Genomes functional enrichment analyses to identify genes related to the independent subtypes. We also integrated mRNA expression data into our bioinformatics analysis.

RESULTS

We identified 4227 TME-associated genes and 640 genes related to the prognosis of HCC. We defined two major subtypes (Clusters 1 and 2) based on the analysis of TME-associated gene expression. Cluster 1 was characterized by increased expression of immune-associated genes and a worse prognosis than Cluster 2.

CONCLUSIONS

The identification of these HCC subtypes based on the TME provides further insight into the molecular mechanisms and prediction of HCC prognosis.

摘要

背景

肝细胞癌(HCC)是一种高度恶性肿瘤,预后尤其差。肿瘤微环境(TME)与肿瘤发生、进展和治疗密切相关。然而,TME 基因与 HCC 患者预后的关系尚不清楚。

方法

本研究基于癌症基因组图谱和基因表达综合数据库的数据,采用微环境细胞群体计数法评估 HCC 中的免疫细胞浸润。使用 Limma 包计算分子亚型之间差异表达的基因,并使用 clusterProfiler 进行基因本体论和京都基因与基因组百科全书功能富集分析,以鉴定与独立亚型相关的基因。我们还将 mRNA 表达数据整合到我们的生物信息学分析中。

结果

我们确定了 4227 个与 TME 相关的基因和 640 个与 HCC 预后相关的基因。我们根据 TME 相关基因表达的分析定义了两个主要亚型(簇 1 和簇 2)。簇 1 的特点是免疫相关基因表达增加,预后比簇 2差。

结论

基于 TME 识别这些 HCC 亚型为 HCC 的分子机制和预后预测提供了更深入的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/7c48746292e4/10.1177_0300060520980646-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/eb4386b22a27/10.1177_0300060520980646-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/a015c1c2a5a9/10.1177_0300060520980646-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/937709cec155/10.1177_0300060520980646-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/76e56df0b1ea/10.1177_0300060520980646-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/7c48746292e4/10.1177_0300060520980646-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/eb4386b22a27/10.1177_0300060520980646-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/a015c1c2a5a9/10.1177_0300060520980646-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/937709cec155/10.1177_0300060520980646-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/76e56df0b1ea/10.1177_0300060520980646-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd3/7883156/7c48746292e4/10.1177_0300060520980646-fig5.jpg

相似文献

1
An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.基于肿瘤微环境的肝细胞癌独立不良预后亚型。
J Int Med Res. 2021 Feb;49(2):300060520980646. doi: 10.1177/0300060520980646.
2
Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.基于肝癌微环境构建风险评分预后模型。
World J Gastroenterol. 2020 Jan 14;26(2):134-153. doi: 10.3748/wjg.v26.i2.134.
3
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.肝细胞癌肿瘤微环境中的预后基因鉴定。
Front Immunol. 2021 Apr 7;12:653836. doi: 10.3389/fimmu.2021.653836. eCollection 2021.
4
Three molecular subtypes and a five-gene signature for hepatocellular carcinoma based on m7G-related classification.基于 m7G 相关分类的肝细胞癌三种分子亚型和五个基因特征。
J Gene Med. 2024 Jan;26(1):e3611. doi: 10.1002/jgm.3611. Epub 2023 Oct 17.
5
Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma.鉴定和免疫分析肝癌肿瘤微环境中的关键预后基因。
Bioengineered. 2021 Dec;12(1):1555-1575. doi: 10.1080/21655979.2021.1918538.
6
Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.肝细胞癌肿瘤微环境中预后相关肿瘤微环境基因的生物信息学分析。
Med Sci Monit. 2020 Mar 31;26:e922159. doi: 10.12659/MSM.922159.
7
Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma.从 TCGA 数据库挖掘与肝癌预后相关的肿瘤微环境基因。
Biomed Res Int. 2019 Nov 19;2019:2408348. doi: 10.1155/2019/2408348. eCollection 2019.
8
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC).肝细胞癌(HCC)肿瘤微环境中预后免疫相关基因的综合分析。
Medicine (Baltimore). 2021 Oct 1;100(39):e27332. doi: 10.1097/MD.0000000000027332.
9
Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma.癌症相关成纤维细胞相关基因特征在肝细胞癌中的预后价值。
Front Endocrinol (Lausanne). 2022 Jun 6;13:884777. doi: 10.3389/fendo.2022.884777. eCollection 2022.
10
Gene mining of immune microenvironment in hepatocellular carcinoma.肝细胞癌免疫微环境的基因挖掘。
Medicine (Baltimore). 2022 Sep 2;101(35):e30453. doi: 10.1097/MD.0000000000030453.

引用本文的文献

1
Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma.基于脂肪酸代谢的整合分析能有力地预测软组织肉瘤的预后、剖析免疫微环境并辅助免疫治疗。
Front Genet. 2023 Mar 30;14:1161791. doi: 10.3389/fgene.2023.1161791. eCollection 2023.
2
The advanced development of molecular targeted therapy for hepatocellular carcinoma.肝细胞癌的分子靶向治疗的进展。
Cancer Biol Med. 2022 Jun 15;19(6):802-17. doi: 10.20892/j.issn.2095-3941.2021.0661.
3
CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.

本文引用的文献

1
Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic Significance.肝细胞癌肿瘤免疫微环境及相关基因的综合研究确定了潜在的预后意义。
Front Oncol. 2020 Sep 24;10:554165. doi: 10.3389/fonc.2020.554165. eCollection 2020.
2
A new risk model comprising genes highly correlated with CD133 identifies different tumor-immune microenvironment subtypes impacting prognosis in hepatocellular carcinoma.一个包含与 CD133 高度相关的基因的新风险模型可识别不同的肿瘤免疫微环境亚型,影响肝细胞癌的预后。
Aging (Albany NY). 2020 Jun 20;12(12):12234-12250. doi: 10.18632/aging.103409.
3
CDKN2A 是肝细胞癌的预后生物标志物,并与免疫浸润相关。
Biosci Rep. 2021 Oct 29;41(10). doi: 10.1042/BSR20211103.
4
Biomarkers in Hepatobiliary Cancers: What is Useful in Clinical Practice?肝胆癌中的生物标志物:在临床实践中有哪些有用的?
Cancers (Basel). 2021 May 30;13(11):2708. doi: 10.3390/cancers13112708.
Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy.
肿瘤微环境相关的树突状细胞缺陷:增强肿瘤免疫治疗的一个靶点。
Pharmacol Res. 2020 Sep;159:104980. doi: 10.1016/j.phrs.2020.104980. Epub 2020 Jun 3.
4
Functional and metabolic targeting of natural killer cells to solid tumors.自然杀伤细胞对实体瘤的功能和代谢靶向。
Cell Oncol (Dordr). 2020 Aug;43(4):577-600. doi: 10.1007/s13402-020-00523-7. Epub 2020 Jun 2.
5
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy.解析晚期卵巢癌肿瘤免疫异质性揭示化疗的免疫原性效应。
Nat Genet. 2020 Jun;52(6):582-593. doi: 10.1038/s41588-020-0630-5. Epub 2020 Jun 1.
6
Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.分析肺腺癌的免疫相关特征,确定了两种不同的亚型:对免疫检查点阻断治疗的影响。
Aging (Albany NY). 2020 Feb 24;12(4):3312-3339. doi: 10.18632/aging.102814.
7
Epidemiology and surveillance for hepatocellular carcinoma: New trends.肝癌的流行病学和监测:新趋势。
J Hepatol. 2020 Feb;72(2):250-261. doi: 10.1016/j.jhep.2019.08.025.
8
B cells and tertiary lymphoid structures promote immunotherapy response.B 细胞和三级淋巴结构促进免疫治疗反应。
Nature. 2020 Jan;577(7791):549-555. doi: 10.1038/s41586-019-1922-8. Epub 2020 Jan 15.
9
Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set.基于免疫相关基因集表达预测肝细胞癌预后。
Aging (Albany NY). 2020 Jan 12;12(1):965-977. doi: 10.18632/aging.102669.
10
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.一种独特肿瘤免疫微环境定义的乳腺癌独立不良预后亚型。
Nat Commun. 2019 Dec 3;10(1):5499. doi: 10.1038/s41467-019-13329-5.